Accrued Expenses

9 Months Ended

Sep. 30, 2024

Accrued Expenses

Accrued Expenses

Note 3. Accrued Expenses

The following is a summary of the Company’s accrued expenses:

	September 30,		December 31,
	2024		2023
Clinical trial expenses	$	951,029	$	1,993,784
Other		412,206		424,218
Total	$	1,363,235	$	2,418,002